INS and metabolic disease: Notably, in a recent meta-analysis of 24 RCTs in patients with metabolic diseases, ALA was also found to improve glucose homeostasis (decreased FBG, insulin, HOMA-IR and HbA1c) and lipid profile (decreased triglycerides, total cholesterol and LDL-cholesterol) (149).